Status:
ENROLLING_BY_INVITATION
Effect of Myofascial Release Technique Alone or Combined With Exercises on Cervical Cobb Angle, Sleep Quality, and Psychological Factors in Patients With Cervicogenic Headache
Lead Sponsor:
Al-Azhar University
Conditions:
Effect of Physiotherapy on Cobb Angle in Patients With Cervicogenic Headache
Eligibility:
All Genders
20-55 years
Phase:
NA
Brief Summary
This study will investigate whether myofascial release therapy alone or in combination with therapeutic exercises can improve cervical spine alignment, measured by cervical Cobb angle on X-ray, in pat...
Eligibility Criteria
Inclusion
- Age 20-55 years.
- Clinical diagnosis of cervicogenic headache according to International Classification of Headache Disorders (ICHD-3) criteria (headache attributed to cervical disorder).
Exclusion
- History of major cervical spine pathology such as fracture, dislocation, congenital malformation, tumor, infection, or inflammatory arthritis (e.g., rheumatoid arthritis, ankylosing spondylitis).
- Previous cervical spine surgery or fusion at any level.
- Red flag symptoms indicating serious pathology (e.g., progressive neurological deficit, unexplained weight loss, fever, history of cancer).
- Systemic or neurological disorders that may affect neck function or headache (e.g., multiple sclerosis, Parkinson's disease).
- Severe osteoporosis or metabolic bone disease that contraindicates cervical X-ray imaging.
- Vascular disorders such as vertebrobasilar insufficiency or carotid artery disease.
- Pregnancy or breastfeeding (due to radiation exposure during cervical radiography).
- Unstable psychiatric conditions (e.g., severe depression, psychosis) that may interfere with participation or adherence.
- Recent physiotherapy or manual therapy targeting the cervical region within the past 6 weeks, or planned during the study outside the protocol.
- Use of botulinum toxin or steroid injections to the neck or head region in the past 6 months.
- Contraindications to manual therapy or exercise (e.g., acute cervical disc herniation, severe myelopathy, unstable cardiovascular disease).
- Inability to understand study procedures, comply with treatment sessions, or provide informed consent.
- Symptoms of migraine, tension-type headache (TTH), or any other headache apart from cervicogenic headache.
Key Trial Info
Start Date :
September 4 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 3 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07168512
Start Date
September 4 2025
End Date
April 3 2026
Last Update
September 11 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Naser Medical Complex
Gaza, Gaza Strip, Palestinian Territories
2
Ministry of Health
Gaza, Palestinian Territories